Armistice Capital
MDCX icon

Armistice Capital’s Medicus Pharma MDCX Stock Holding History

Armistice Capital’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,219
Closed -$2.77M – 459
2025
Q4 		$2.77M Buy
+36,219
New +$3.88M 0.03% 149
2025
Q2 		– Sell
-25,320
Closed -$4.71M – 284
2025
Q1 		$4.71M Buy
+25,320
New +$3.98M 0.07% 116

Other funds holding MDCX

Interchange Capital Partners
Interchange Capital Partners Pittsburgh, Pennsylvania $598M AUM 31.79% 1-Year Est. Return
Private Advisor Group
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Virtu Financial
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Wilmington Savings Fund Society
Wilmington Savings Fund Society Wilmington, Delaware $4.39B AUM 17.99% 1-Year Est. Return
May Hill Capital
May Hill Capital Cohasset, Massachusetts $510M AUM 23.75% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Securities
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Armistice Capital's MDCX Position: Q1 2026 in Review

Armistice Capital sold out of Medicus Pharma (MDCX) in Q1 2026, closing a stake of 36,219 shares — an estimated $2.77M sold.

Armistice Capital first reported a position in MDCX in Q1 2025 and held it in 2 quarters. The position peaked at $4.71M in Q1 2025. 21 funds tracked by Wall St. Rank hold MDCX as of Q1 2026.

  • Armistice Capital reported no remaining Medicus Pharma position as of Q1 2026 after selling out during the quarter.
  • Armistice Capital sold 36,219 Medicus Pharma shares in Q1 2026, an estimated $2.77M.
  • Armistice Capital first reported a position in Medicus Pharma in Q1 2025 and held it in 2 quarters.
  • Armistice Capital's Medicus Pharma position peaked at $4.71M in Q1 2025.
  • 21 funds tracked by Wall St. Rank held Medicus Pharma as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.